The plasticity of mRNA translation during cancer progression and therapy resistance

L Fabbri, A Chakraborty, C Robert, S Vagner - Nature Reviews Cancer, 2021 - nature.com
Translational control of mRNAs during gene expression allows cells to promptly and
dynamically adapt to a variety of stimuli, including in neoplasia in response to aberrant …

Research progress of mTOR inhibitors

Y Chen, X Zhou - European journal of medicinal chemistry, 2020 - Elsevier
Mammalian target of rapamycin (mTOR) is a highly conserved Serine/Threonine (Ser/Thr)
protein kinase, which belongs to phosphatidylinositol-3-kinase-related kinase (PIKK) protein …

New frontiers in translational control of the cancer genome

ML Truitt, D Ruggero - Nature Reviews Cancer, 2016 - nature.com
The past several years have seen dramatic leaps in our understanding of how gene
expression is rewired at the translation level during tumorigenesis to support the …

mTORC1 as a regulator of mitochondrial functions and a therapeutic target in cancer

KG de la Cruz López, ME Toledo Guzmán… - Frontiers in …, 2019 - frontiersin.org
Continuous proliferation of tumor cells requires constant adaptations of energy metabolism
to rapidly fuel cell growth and division. This energetic adaptation often comprises …

mTOR: from growth signal integration to cancer, diabetes and ageing

R Zoncu, A Efeyan, DM Sabatini - Nature reviews Molecular cell biology, 2011 - nature.com
In all eukaryotes, the target of rapamycin (TOR) signalling pathway couples energy and
nutrient abundance to the execution of cell growth and division, owing to the ability of TOR …

The central moTOR of metabolism

J Simcox, DW Lamming - Developmental cell, 2022 - cell.com
The protein kinase mechanistic target of rapamycin (mTOR) functions as a central regulator
of metabolism, integrating diverse nutritional and hormonal cues to control anabolic …

Differential requirements for eIF4E dose in normal development and cancer

ML Truitt, CS Conn, Z Shi, X Pang, T Tokuyasu… - Cell, 2015 - cell.com
Summary eIF4E, the major cap-binding protein, has long been considered limiting for
translating the mammalian genome. However, the eIF4E dose requirement at an organismal …

Upstream and downstream of mTOR

N Hay, N Sonenberg - Genes & development, 2004 - genesdev.cshlp.org
The evolutionarily conserved checkpoint protein kinase, TOR (target of rapamycin), has
emerged as a major effector of cell growth and proliferation via the regulation of protein …

eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation

AC Gingras, B Raught… - Annual review of …, 1999 - annualreviews.org
▪ Abstract Eukaryotic translation initiation factor 4F (eIF4F) is a protein complex that mediates
recruitment of ribosomes to mRNA. This event is the rate-limiting step for translation under …

Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism

K Hara, K Yonezawa, QP Weng, MT Kozlowski… - Journal of Biological …, 1998 - ASBMB
The present study identifies the operation of a signal tranduction pathway in mammalian
cells that provides a checkpoint control, linking amino acid sufficiency to the control of …